T TITAN PHARMACEUTICALS - Trademark Details
Status: 700 - Registered
Serial Number
87278812
Registration Number
5782129
Word Mark
T TITAN PHARMACEUTICALS
Status
700 - Registered
Status Date
2019-06-18
Filing Date
2016-12-22
Registration Number
5782129
Registration Date
2019-06-18
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260102, 260121, 260508, 260521, 270301 - Plain single line circles. Circles that are totally or partially shaded. Letters, numerals or punctuation forming the perimeter of a triangle, bordering the perimeter of a triangle or forming a triangle. Triangles that are completely or partially shaded. Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2018-08-28
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
FERRAIUOLO, DOMINIC J
Statements
Indication of Colors claimed
The color(s) red, black and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMACEUTICALS"
Description of Mark
The mark consists of the stylized wording "TITAN PHARMACEUTICALS" in black adjacent to a design comprising a stylized letter "T" with the left half in color red, a triangle in color red with a dot in the middle in color white and the rest of the letter "T" in color white.
Goods and Services
Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-01-06
Primary Code
005
First Use Anywhere Date
2019-02-26
First Use In Commerce Date
2019-02-26
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
JENNIFER LEE TAYLOR
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0067844
Original Filing Date USPTO
2017-06-16
International Registration Number
1366454
International Registration Date
2017-06-16
International Status Code
480
International Renewal Date
2027-06-16
| Madrid History Events | ||
| Date | Code | Description |
| 2017-08-16 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2019-10-03 | CBNAR | CEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 2017-08-05 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
| 2017-08-15 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2017-06-16 | ACERT | AUTOMATICALLY CERTIFIED |
| 2017-06-16 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2017-06-16 | APPST | IR CERTIFIED AND SENT TO IB |
| 2019-09-18 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2017-09-28 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2017-08-16 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
Trademark Events
| Event Date | Event Description |
| 2016-12-27 | NEW APPLICATION ENTERED IN TRAM |
| 2017-01-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2017-01-07 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2017-01-08 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| 2017-01-08 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| 2017-03-22 | ASSIGNED TO EXAMINER |
| 2017-03-29 | NON-FINAL ACTION WRITTEN |
| 2017-03-29 | NON-FINAL ACTION E-MAILED |
| 2017-03-29 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2017-09-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2017-09-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-09-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-10-09 | SUSPENSION LETTER WRITTEN |
| 2017-10-09 | LETTER OF SUSPENSION E-MAILED |
| 2017-10-09 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2018-03-28 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2018-04-13 | ASSIGNED TO LIE |
| 2018-04-17 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| 2018-07-25 | EXAMINERS AMENDMENT -WRITTEN |
| 2018-07-25 | EXAMINERS AMENDMENT E-MAILED |
| 2018-07-25 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2018-07-25 | EXAMINER'S AMENDMENT ENTERED |
| 2018-07-25 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2018-08-08 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2018-08-28 | PUBLISHED FOR OPPOSITION |
| 2018-08-28 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2018-10-23 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2019-04-17 | TEAS EXTENSION RECEIVED |
| 2019-04-17 | EXTENSION 1 FILED |
| 2019-04-17 | EXTENSION 1 GRANTED |
| 2019-04-19 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-04-23 | TEAS STATEMENT OF USE RECEIVED |
| 2019-05-05 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2019-04-23 | USE AMENDMENT FILED |
| 2019-05-05 | STATEMENT OF USE PROCESSING COMPLETE |
| 2019-05-16 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2019-05-17 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2019-06-18 | REGISTERED-PRINCIPAL REGISTER |
